FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 21 filers reported holding FREELINE THERAPEUTICS HLDGS in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $3,518,000 | -46.5% | 1,776,613 | -7.9% | 0.17% | -50.9% |
Q3 2021 | $6,575,000 | -65.8% | 1,928,157 | -18.3% | 0.34% | -60.2% |
Q2 2021 | $19,244,000 | -33.7% | 2,361,229 | 0.0% | 0.85% | -28.8% |
Q1 2021 | $29,043,000 | -32.6% | 2,361,229 | 0.0% | 1.20% | -35.1% |
Q4 2020 | $43,116,000 | +315.3% | 2,361,229 | +255.1% | 1.85% | +258.8% |
Q3 2020 | $10,381,000 | – | 665,000 | – | 0.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 1,379,843 | $11,246,000 | 2.62% |
Novo Holdings A/S | 2,361,229 | $19,244,000 | 0.85% |
Ally Bridge Group (NY) LLC | 401,747 | $3,274,000 | 0.81% |
SECTORAL ASSET MANAGEMENT INC | 640,714 | $5,222,000 | 0.42% |
FRAZIER MANAGEMENT LLC | 550,000 | $4,483,000 | 0.41% |
TFG Asset Management GP Ltd | 750,000 | $6,113,000 | 0.33% |
Eventide Asset Management | 2,485,656 | $19,757,000 | 0.26% |
AXA S.A. | 1,111,510 | $9,058,000 | 0.01% |
Woodline Partners LP | 25,932 | $211,000 | 0.00% |
WELLINGTON MANAGEMENT GROUP LLP | 2,001,951 | $16,315,000 | 0.00% |